These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. Klein RQ; Teal V; Taylor L; Troxel AB; Werth VP J Am Acad Dermatol; 2007 Dec; 57(6):937-43. PubMed ID: 17923170 [TBL] [Abstract][Full Text] [Related]
8. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management. Walling HW; Gerami P; Sontheimer RD Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339 [TBL] [Abstract][Full Text] [Related]
10. The clinical features, diagnosis and classification of dermatomyositis. Iaccarino L; Ghirardello A; Bettio S; Zen M; Gatto M; Punzi L; Doria A J Autoimmun; 2014; 48-49():122-7. PubMed ID: 24467910 [TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department. Tang K; Zhang H; Jin H Front Med (Lausanne); 2021; 8():783416. PubMed ID: 34926528 [No Abstract] [Full Text] [Related]
12. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Chen YJ; Wu CY; Shen JL Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544 [TBL] [Abstract][Full Text] [Related]
13. Dermatomyositis associated with omalizumab therapy for severe asthma: a case report. Jeimy S; Basharat P; Lovegrove F Allergy Asthma Clin Immunol; 2019; 15():4. PubMed ID: 30675173 [TBL] [Abstract][Full Text] [Related]
14. Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. Sunderkötter C; Nast A; Worm M; Dengler R; Dörner T; Ganter H; Hohlfeld R; Melms A; Melzer N; Rösler K; Schmidt J; Sinnreich M; Walter MC; Wanschitz J; Wiendl H J Dtsch Dermatol Ges; 2016 Mar; 14(3):321-38. PubMed ID: 26972210 [TBL] [Abstract][Full Text] [Related]
15. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. Yamasaki Y; Yamada H; Ohkubo M; Yamasaki M; Azuma K; Ogawa H; Mizushima M; Ozaki S J Rheumatol; 2011 Aug; 38(8):1636-43. PubMed ID: 21572147 [TBL] [Abstract][Full Text] [Related]
17. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets. Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683 [TBL] [Abstract][Full Text] [Related]
18. A case of Amyopathic Dermatomyositis associated with Interstitial Pulmonary Disease. Ugan Y; Sahin M; Dogru A; Bayram D; Ceyhan AM; Tunc SE Clin Ter; 2015; 166(6):253-5. PubMed ID: 26794813 [TBL] [Abstract][Full Text] [Related]
19. Statin-induced dermatomyositis for the practicing dermatologist: a review of the literature. Visconti MJ; Bashyam AM; Jorizzo JL Int J Dermatol; 2020 Mar; 59(3):383-387. PubMed ID: 31840246 [TBL] [Abstract][Full Text] [Related]
20. The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria. Concha JSS; Tarazi M; Kushner CJ; Gaffney RG; Werth VP Br J Dermatol; 2019 May; 180(5):1001-1008. PubMed ID: 30561064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]